ÂÜÀòÂÒÂ×

Christopher Kelly has held various executive positions since 2014. Christopher began their career as the Chief Operating Officer of Esperer Holdings, LLC, a rapidly growing private equity acquisitions and back office support company. In 2016, they became the Chief Executive Officer of Carbon Sciences, Inc., a publicly traded company developing breakthrough technologies based on graphene. In 2017, they were the Chief Executive Officer of AdYoYo Inc., a Las Vegas based tech startup that offers a unique online video marketplace app. In 2018, they became the CEO & Founder of MedElite Capital, a medical finance and lien purchasing company. In 2020, they joined US Capital Global as a Vice President. Currently, they are the Chief Executive Officer of OrthoLazer and Agravitae.

Christopher Kelly obtained a Doctor of Law (J.D.) from the University of Denver - Sturm College of Law between 2006 and 2009. Christopher also obtained a Bachelor of Arts (B.A.) from Brigham Young University between 1999 and 2005.